Tenex drums up $1.3 million
March 16, 2010 by MedCity News
Tenex Health Inc., led by former Boston Scientific executive Jagi Gill, raises $1.3 million in an equity sale.
By Thomas Lee
Tenex Health Inc. raised $1.3 million from the sale of equity, according to a filing with the Securities & Exchange Commission.
The Rochester, Minn.-based biotech start-up, which is seeking a total of $2 million, is developing treatments for sports-related injuries such as tendinitis.
Founder and CEO Jagi Gill did not return a phone call seeking comment.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
Navigation
NEWS
European regulators green-light valve-in-valve procedures
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
Biosense Webster launches Afib ablation study for nMARQ system
Johnson & Johnson subsidiary Biosense Webster enrolls its 1st patient in the reMARQable clinical...
GPO: Healthcare collaborative teams up within the Premier network
Four health systems create a collaborative group as part of the Premier network
Agea Medical has its sights on an $8 million offering
Agea Medical is $2 million shy of its $8 million funding round goal
FDA panel to consider down-classifying blade-form dental implants
The FDA's Dental Products Panel is scheduled to deliberate on whether the agency should lower blade-...
